Ph chromosome positive acute lymphoblastic leukemia patients with a e1a3 BCR-ABL fusion gene and T315I mutation:One case report and literature review
Ying Dong,Ruifeng Yuan,Huafeng Zhu,Miaojuan Feng,Ziwei Chang,Liping Hou,Xiaoli Xin,Shan Gao,Shuchun Yu,Xiaoli Su,Yaping Zhao,Zhiqiang Tian,Xiequn Chen,Guangxun Gao
DOI: https://doi.org/10.3969/j.issn.1672-4992.2018.11.025
2018-01-01
Journal of Modern Oncology
Abstract:Objective:To analyse the unusual BCR-ABL fusion gene structure of one patient with Ph chromosome positive acute lymphoblastic leukemia(ALL).To combine with literature review,we describe its clinical and biologi-cal characteristics.Methods:By using bone marrow cell morphology and flow cytometry to determine the type of leu-kemia and the immunophenotype,conventional chromosome and fluorescence in situ hybridization to determine the cy-togenetic abnormalities,real-time fluorescence quantitative PCR(RQ-PCR)method to determine the specific type of BCR-ABL fusion gene and the copy number.At the same time,we were underway of the Systematic review of the literature.Results:The patient showed the clinical manifestations of ALL,with Ph chromosome positive.However,no amplification curve was detected by using the conventional BCR-ABL kit,further detected with BCR-ABL rare fu-sion gene kit,found e1a3 BCR-ABL fusion gene.After dasatinib combined with VICP chemotherapy,the disease was complete remission,then to consolidate and strengthen treatment.After five mounths,the disease was relapse.At this point,T315I mutation was detected.The disease was remission by the remission induction therapy.Finally,the patient died of infection only 6 months from the onset.Conclusion:The uncommon e1a3 BCR-ABL fusion gene may occur in patient with Ph chromosome positive ALL and produce unusual RQ-PCR amplification bands.Combined with liter-ature review,the treatment response and prognosis of pure ela3 BCR-ABL ph+ALL were not significantiy different from other types,but the prognosis of ALL with T315I mutation was still poor.